Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Foundation Medicine will provide a personalized picture of a patient’s disease.
A startup is targeting diseases including cancer using epigenetic approaches.
Understanding the different populations of mutant cells in a cancer could mean more targeted treatments.
Scientists use synthetic biology to create drug-controlled T cells.
Sequencing the genomes of both healthy and cancer cells from the same patient hints at how cancer metastasizes.
A number of dual-action antibodies are in clinical trials for fighting cancer.
By automating the tracking of tumor cells that circulate in the blood, doctors can see if a cancer treatment is working.
In first human trial, particles successfully reach cancer cells and silence the target gene.
Molecules that make blood vessels more permeable might boost chemotherapeutics.